Suzuki, Hidenori https://orcid.org/0000-0002-3156-0591
Kaito, Takashi
Nakashima, Hiroaki
Takahashi, Hiroshi
Yamamoto, Shuhei
Tabata, Shunsuke
Toyoda, Hiromitsu
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Received: 29 May 2025
Accepted: 8 September 2025
First Online: 17 October 2025
Declarations
:
: Hidenori Suzuki, Takashi Kaito, and Hiroaki Nakashima have no conflicts of interest in relation to the submitted work. Hiroshi Takahashi, Shuhei Yamamoto, and Shunsuke Tabata are employees of Daiichi Sankyo Co., Ltd. Hiromitsu Toyoda has received lecture fees from Daiichi Sankyo Co., Ltd.
: The study was approved by Yamaguchi University Certified Review Board (CRB6180002). The study was conducted in accordance with the Clinical Trials Act in Japan, under which clinical research is only required to undergo a central ethical review, as well as the ethical principles and relevant notifications stipulated in the Declaration of Helsinki (as revised in 2013). This study was registered in the Japan Registry of Clinical Trials under the identifier jRCTs061220102. All participants provided informed consent to participate in the study.